An interactive Shiny application for exploring transcriptomic data from the NYGC ALS Consortium allowing researchers to visualize differential gene expression across tissues, genetic subtypes, and clinical variables in ALS and control post-mortem samples.
The Center of Genomics of Neurodegenerative Diseases (CGND) flagship ALS manuscripts present a comprehensive analysis of the full consortium cohort, focusing on RNA-seq and whole genome sequencing (WGS) data generated from post-mortem tissue samples collected from ALS patients and neurologically normal controls.
The ALS Gene Browser provides an accessible, point-and-click interface for researchers to query gene-level results without requiring direct interaction with raw data or analysis pipelines.
| Feature | Details |
|---|---|
| Data types | RNA-seq, clinical metadata |
| Sample types | Post-mortem human tissue |
| Groups | ALS cases, Neurologically normal controls |
| Contributing sites | 41 sites across the NYGC ALS Consortium |
| Tissues profiled | 5 major CNS and non-CNS tissues (see below) |
- Motor Cortex (MCX)
- Frontal Cortex (FCX)
- Cervical Spinal Cord (CSC)
- Lumbar Spinal Cord (LSC)
- Cerebellum (CBL)
The browser is organized into two main tabs
Explore differential gene expression (DEG) results comparing gene expression data from ALS samples to neurologically normal controls across all five tissues.
- Enter a gene of interest in the gene input field (HGNC symbol, e.g.,
TARDBP,FUS,SOD1). - The app will return results across all five tissues simultaneously.
- Displays normalized expression of the selected gene across ALS and control samples, faceted by tissue.
- Summary of differential expression statistics for the queried gene in each tissue.
- Includes fold change (LFC), p-value, adjusted p-value (FDR), and direction of effect.
- DEG includes covariate selection (see paper)
- A positive LFC shows higher gene expression in ALS cases compared to controls.
- A negative LFC shows higher genne expression in controls compared to ALS cases.
- DEG analysis was performed using robust covariates to account for sample collection across multiple contributing sites. (see paper)
- Covariate correction mitigates batch effects introduced by cross-site variability in sample handling, RNA extraction, and sequencing. (see paper)
Explore gene expression patterns **within ALS cases **, stratified by C9orf72 repeat expansion status and correlated with key clinical variables including age at symptom onset and disease duration.
- Enter a gene of interest in the gene input field.
- Select a tissue from the five available tissues using the dropdown menu.
- Visualizes expression of the selected gene comparing C9orf72-positive vs. C9orf72-negative ALS cases in the chosen tissue.
- Age at Death vs. Gene Expression — scatter plot showing the relationship between expression and age at death across ALS cases.
- Disease Duration vs. Gene Expression — scatter plot showing the relationship between expression and disease duration (time from symptom onset to death).
- Results from three complementary analyses:
- Summary of differential expression statistics for the queried gene in each tissue.
- Includes fold change, p-value, adjusted p-value (FDR), and direction of effect.
- C9orf72 status (categorical): DEG between C9orf72-positive and C9orf72-negative cases.
- Age at Death (continuous): Association between gene expression and age at death.
- Disease Duration (continuous): Association between gene expression and disease duration.
- All analyses use DESeq2 for count-based differential expression modeling.
- For Motor Cortex only, analyses were additionally run using DREAM (differential expression for repeated measures).
ALS_Gene_Browser/
├── app.R # Main Shiny application (or ui.R + server.R)
├── data/
│ ├── deg_als_vs_ctrl.rds # DEG results: ALS vs. Control (Tab 1)
│ ├── deg_case_only_results.rds # DEG results: C9orf72 pos vs. neg (Tab 2)
│ └── tpm_data.rds # Normalized expression across all samples
└── README.md
If you use this browser or the underlying data in your research, please cite the NYGC ALS Consortium flagship manuscript:
[Full citation to be added upon publication]
For questions about the browser or the underlying data, please contact the Center of Genomics of Neurodegenerative Diseases (CGND) at the New York Genome Center.